» Articles » PMID: 39867898

Developing and Validating a Machine Learning Model to Predict Multidrug-resistant -related Septic Shock

Overview
Journal Front Immunol
Date 2025 Jan 27
PMID 39867898
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Multidrug-resistant Klebsiella pneumoniae (MDR-KP) infections pose a significant global healthcare challenge, particularly due to the high mortality risk associated with septic shock. This study aimed to develop and validate a machine learning-based model to predict the risk of MDR-KP-associated septic shock, enabling early risk stratification and targeted interventions.

Methods: A retrospective analysis was conducted on 1,385 patients with MDR-KP infections admitted between January 2019 and June 2024. The cohort was randomly divided into a training set (n = 969) and a validation set (n = 416). Feature selection was performed using LASSO regression and the Boruta algorithm. Seven machine learning algorithms were evaluated, with logistic regression chosen for its optimal balance between performance and robustness against overfitting.

Results: The overall incidence of MDR-KP-associated septic shock was 16.32% (226/1,385). The predictive model identified seven key risk factors: procalcitonin (PCT), sepsis, acute kidney injury, intra-abdominal infection, use of vasoactive medications, ventilator weaning failure, and mechanical ventilation. The logistic regression model demonstrated excellent predictive performance, with an area under the receiver operating characteristic curve (AUC) of 0.906 in the training set and 0.865 in the validation set. Calibration was robust, with Hosmer-Lemeshow test results of = 0.065 (training) and = 0.069 (validation). Decision curve analysis indicated substantial clinical net benefit.

Conclusion: This study presents a validated, high-performing predictive model for MDR-KP-associated septic shock, offering a valuable tool for early clinical decision-making. Prospective, multi-center studies are recommended to further evaluate its clinical applicability and effectiveness in diverse settings.

References
1.
Sauerbrei W, Perperoglou A, Schmid M, Abrahamowicz M, Becher H, Binder H . State of the art in selection of variables and functional forms in multivariable analysis-outstanding issues. Diagn Progn Res. 2020; 4:3. PMC: 7114804. DOI: 10.1186/s41512-020-00074-3. View

2.
Cottrell S, Hozumi Y, Wei G . K-nearest-neighbors induced topological PCA for single cell RNA-sequence data analysis. Comput Biol Med. 2024; 175:108497. PMC: 11090715. DOI: 10.1016/j.compbiomed.2024.108497. View

3.
Wang Y, Wang J, He J, Ji B, Pang Z, Wang J . Comprehensive analysis of PRPF19 immune infiltrates, DNA methylation, senescence-associated secretory phenotype and ceRNA network in bladder cancer. Front Immunol. 2023; 14:1289198. PMC: 10657824. DOI: 10.3389/fimmu.2023.1289198. View

4.
Lee S, Gornitz N, Xing E, Heckerman D, Lippert C . Ensembles of Lasso Screening Rules. IEEE Trans Pattern Anal Mach Intell. 2018; 40(12):2841-2852. PMC: 6925025. DOI: 10.1109/TPAMI.2017.2765321. View

5.
Riley R, Ensor J, Snell K, Harrell Jr F, Martin G, Reitsma J . Calculating the sample size required for developing a clinical prediction model. BMJ. 2020; 368:m441. DOI: 10.1136/bmj.m441. View